Elderly Who Start Thiopurine Tx for IBD Have Higher Risk for AEs
Advanced age, female gender are independent risk factors for adverse events
Read More
Author: Janine Anthes
Incidence of HPV-Positive Head and Neck Cancer Up in the U.S.
From 2013 to 2014, incidence of HPV-positive oropharyngeal cancers was 4.62 per 100,000 persons
Read More
Asthma-Related ED Use Up for Children With Anxiety, Depression
Children with asthma and anxiety, depression, or both have increased rates of asthma-linked ED use
Read More
Uptitration of Drugs Varies With Target Dosage in Chronic HF
When target is higher versus lower dosage, uptitration stops further from recommended dosage
Read More
Food Insecurity Prevalent Among Medicare Enrollees
Odds of food insecurity up with reporting four or more chronic conditions, depression, anxiety
Read More
Marine Omega-3 Supplements May Lower CVD Risk
Updated meta-analysis shows lower risks for MI, CHD death, total CHD, CVD death, total CVD
Read More
Decrease in Stroke Incidence Continued Through 2017 in ARIC
Decrease in stroke rates for 1987 to 2011 extended to 2017; decrease seen across decades, sex, race
Read More
Glycemic Control Worse Than Thought in Adults With T1DM
Rates of both acute and chronic complications significantly increase with increasing HbA1c
Read More
Some Nutritional Supplements May Aid Mental Health Conditions
Nutrient supplements had good safety profiles, no known contraindications with psychiatric medications
Read More
USPSTF Finds Evidence Lacking to Prevent Illicit Drug Use in Youth
Evidence insufficient to recommend primary care interventions to prevent, cut drug use in youth
Read More
No Benefit Found for High-Dose Vitamin C Infusions in Sepsis, ARDS
No differences seen versus placebo in organ dysfunction scores, biomarkers of inflammation or vascular injury
Read More
September 2019 Briefing – Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Average Annual Premium for Workers Increased in 2019 […]
Read More
September 2019 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level of Red, […]
Read More
September 2019 Briefing – Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Heart Disease May Up Risk for Allopurinol-Linked Cutaneous […]
Read More
September 2019 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level […]
Read More
September 2019 Briefing – Family Practice
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level of […]
Read More
September 2019 Briefing – Gastroenterology
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. CVS Halts Sales of OTC Zantac MONDAY, Sept. […]
Read More
September 2019 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Recommendations Updated for Management of Pediatric ADHD MONDAY, […]
Read More
September 2019 Briefing – Nursing
Here are what the editors at HealthDay consider to be the most important developments in Nursing for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level of Red, […]
Read More
September 2019 Briefing – OBGYN & Women’s Health
Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current […]
Read More